Skip to main content
DYAI
NASDAQ Life Sciences

Dyadic's Non-Animal Dairy Enzyme Achieves Milestone, Targets 2026 Commercialization

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.807
Mkt Cap
$28.19M
52W Low
$0.711
52W High
$1.55
52W Position info
14% above low
Off High info
48% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

DYAI is trading near its 52-week low of $0.711 (14% above the low) on light trading volume (0.4× avg).

Summary

Dyadic Applied BioSolutions announced a significant step forward in its collaboration with Inzymes ApS, achieving a key development milestone for their recombinant non-animal bovine chymosin. This enzyme, crucial for cheese production, is now slated for commercialization in 2026. As a result of this achievement, Dyadic received a $200,000 milestone payment and is positioned to earn future royalties from sales in the estimated $1.5-$2.0 billion global dairy processing enzyme market. This progress validates Dyadic's proprietary microbial expression platforms and signals a new potential revenue stream, which is material for a company of its size. Investors will monitor the commercialization timeline and the potential for future royalty income.

At the time of this announcement, DYAI was trading at $0.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.2M. The 52-week trading range was $0.71 to $1.55. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

DYAI - Latest Insights

DYAI
Nov 13, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.327
Real-time Price: $0.3305 info
Change: +$0.0035 (+1%) info
Market Cap: $11.506M info
DYAI
Nov 12, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.3501
Real-time Price: $0.3305 info
Change: -$0.0196 (-6%) info
Market Cap: $11.506M info
DYAI
Sep 25, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4198
Real-time Price: $0.3305 info
Change: -$0.0893 (-21%) info
Market Cap: $11.506M info
DYAI
Aug 17, 2026, 7:27 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.710
Real-time Price: $0.3305 info
Change: -$0.3795 (-53%) info
Market Cap: $11.506M info
DYAI
Aug 14, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7702
Real-time Price: $0.3305 info
Change: -$0.4397 (-57%) info
Market Cap: $11.506M info